Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on Therapeutics

Phase III - Efficacy Study of AMARGOL - Phytomedicine on Therapeutics

This is a Phase 3: Efficacy Study for AMARGOL® a phytomedicine used for asymptomatic digestive complaints.

This study will be performed for proving the efficacy of AMARGOL®, a phytomedicine product, under the Brazilian law for registration and revalidation RDC 14/2010.

AMARGOL® indications are for non specific digestive complaints as laxative and anti-dyspeptic.

Is a mixture of 7 plant extracts: Aloe ferox, Angelica archangelica, Alpinia officinarum, Cinnamomum zeylanicum, Gentiana lutea, Commiphora myrrh and Rheum palmatum.

Placebo controlled test

Inclusion Criteria:

• 18-45 years old
• 65-85 Kg
• healthy volunteers

Exclusion Criteria:

• chronic dyspeptics illness chronic congestive cardiac problems
• pulmonary problems
• diabetes, thyroid problems
• pregnancy
• bowel syndrome
• hemorrhoids
• colitis
• allergies for any formula components.